BioSpace News Archive

Policy

AACC Statement on Non-Invasive Prenatal Screening Tests

We share the FDA’s goal of alerting the public to the potential misuse of non-invasive prenatal screening tests.

April 21, 2022
·
3 min read
Business

NaNotics LLC Appoints Dr. Curtis Ruegg as CDO/COO

NaNotics LLC announced the appointment of Curtis Ruegg, Ph.D., a world-class developer of immune-modulating drugs and nanoparticles, as Chief Development Officer and Chief Operating Officer.

April 21, 2022
·
4 min read
EIB provides €15 million to fund coronavirus research at IRBM

€15 million will be provided to IRBM to expand medical research and development to fight coronavirus and other infectious diseases.

April 21, 2022
·
4 min read
Business

Portal Innovations Announces Partnership with Thermo Fisher Scientific

Portal Innovations today announced that it is partnering with Life Technologies Corporation, part of Thermo Fisher Scientific Inc. (NYSE: TMO) the world leader in serving science and a leading life sciences research provider of innovative technologies.

April 21, 2022
·
2 min read
Newcastle Disease Vaccine Market: The thermostable vaccines segment is anticipated to record significant growth

Albany NY, United States: Newcastle disease is a viral disease caused by avian paramyxovirus type 1.

April 21, 2022
·
6 min read
Jet Injector Device Market: Increased inclination toward minimal invasive methods to drive the market

Albany NY, United States: Jet injector device is a medical device that uses a needle-free injection system.

April 21, 2022
·
6 min read
Recombinant Vector Vaccines Market: The recombinant viral vector vaccines segment holds the maximum share of the market

Albany NY, United States: Scientists need to perform intensive research and study to design a vaccine against particular microbes.

April 21, 2022
·
6 min read
Dutch biotech Xinvento raises seed round to develop a treatment for the rare disease Congenital Hyperinsulinism

Xinvento, a biotech company aiming to improve the lives of those with Congenital Hyperinsulinism, announces the completion of a seed funding round.

April 21, 2022
·
2 min read
Drug Development

AlzeCure Publishes New Data on NeuroRestore and ACD856 from Alzheimer’s Conference

AlzeCure Pharma AB announced that the company’s presentations at the Alzheimer’s conference 2nd Swedish Meeting for Alzheimer Research, regarding the research platform NeuroRestore and its primary drug candidate ACD856, are now available in their entirety on the company’s website.

April 21, 2022
·
4 min read
Deals

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

Wallaby Medical announced that it has acquired phenox GmbH, including phenox’s femtos GmbH, a German-based global innovation and technology leader in the neurovascular space, for a total consideration of approximately EUR 500 million including milestone payments.

April 21, 2022
·
4 min read